SillaJen Inc (215600) - Net Assets

Latest as of September 2025: ₩117.80 Billion KRW ≈ $79.83 Million USD

Based on the latest financial reports, SillaJen Inc (215600) has net assets worth ₩117.80 Billion KRW (≈ $79.83 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩124.38 Billion ≈ $84.29 Million USD) and total liabilities (₩6.58 Billion ≈ $4.46 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore SillaJen Inc asset portfolio for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩117.80 Billion
% of Total Assets 94.71%
Annual Growth Rate 4.73%
5-Year Change 476.13%
10-Year Change N/A
Growth Volatility 139.33

SillaJen Inc - Net Assets Trend (2015–2024)

This chart illustrates how SillaJen Inc's net assets have evolved over time, based on quarterly financial data. Check 215600 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for SillaJen Inc (2015–2024)

The table below shows the annual net assets of SillaJen Inc from 2015 to 2024. For live valuation and market cap data, see market value of SillaJen Inc.

Year Net Assets Change
2024-12-31 ₩131.82 Billion
≈ $89.33 Million
+129.99%
2023-12-31 ₩57.31 Billion
≈ $38.84 Million
-27.40%
2022-12-31 ₩78.94 Billion
≈ $53.50 Million
-26.94%
2021-12-31 ₩108.05 Billion
≈ $73.22 Million
+372.24%
2020-12-31 ₩22.88 Billion
≈ $15.51 Million
-86.14%
2018-12-31 ₩165.09 Billion
≈ $111.88 Million
-18.25%
2017-12-31 ₩201.95 Billion
≈ $136.86 Million
-2.90%
2016-12-31 ₩207.97 Billion
≈ $140.94 Million
+139.23%
2015-12-31 ₩86.94 Billion
≈ $58.91 Million
--

Equity Component Analysis

This analysis shows how different components contribute to SillaJen Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 43371379180000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock ₩68.68 Billion 52.11%
Other Components ₩531.32 Billion 403.08%
Total Equity ₩131.82 Billion 100.00%

SillaJen Inc Competitors by Market Cap

The table below lists competitors of SillaJen Inc ranked by their market capitalization.

Company Market Cap
Solid FAB
ST:SFAB
$200.96 Million
Ohio Valley Banc Corp
NASDAQ:OVBC
$200.97 Million
Maritime Resources Corp.
V:MAE
$200.98 Million
Waldencast Acquisition Corp
NASDAQ:WALD
$201.01 Million
AIRA Capital Public Company Limited
BK:AIRA
$200.77 Million
RCI Hospitality Holdings Inc
NASDAQ:RICK
$200.66 Million
GENFIT S.A. ADR/1 EO-25
F:XUPB
$200.59 Million
Seoyon E Hwa Co Ltd
KO:200880
$200.53 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in SillaJen Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 57,313,962,950 to 131,817,269,900, a change of 74,503,306,950 (130.0%).
  • Net loss of 26,525,745,520 reduced equity.
  • Share repurchases of 103,155,000,000 reduced equity.
  • New share issuances of 103,155,000,000 increased equity.
  • Other factors increased equity by 101,029,052,470.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩-26.53 Billion -20.12%
Share Repurchases ₩103.16 Billion -78.26%
Share Issuances ₩103.16 Billion +78.26%
Other Changes ₩101.03 Billion +76.64%
Total Change ₩- 129.99%

Book Value vs Market Value Analysis

This analysis compares SillaJen Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.23x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 6.71x to 2.23x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 ₩319.81 ₩2145.00 x
2021-12-31 ₩1051.13 ₩2145.00 x
2022-12-31 ₩767.95 ₩2145.00 x
2023-12-31 ₩557.57 ₩2145.00 x
2024-12-31 ₩960.12 ₩2145.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently SillaJen Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -20.12%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -675.53%
  • • Asset Turnover: 0.03x
  • • Equity Multiplier: 1.13x
  • Recent ROE (-20.12%) is above the historical average (-52.56%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -64.25% -3086.09% 0.01x 1.76x ₩-64.55 Billion
2016 -35.60% -1398.97% 0.02x 1.37x ₩-94.84 Billion
2017 -28.24% -830.62% 0.03x 1.16x ₩-77.22 Billion
2018 -34.06% -729.20% 0.04x 1.17x ₩-72.74 Billion
2020 -209.03% -2864.25% 0.04x 2.07x ₩-50.11 Billion
2021 -14.17% -6017.12% 0.00x 1.25x ₩-26.11 Billion
2022 -32.00% -503.80% 0.05x 1.31x ₩-33.15 Billion
2023 -35.54% -517.04% 0.05x 1.34x ₩-26.10 Billion
2024 -20.12% -675.53% 0.03x 1.13x ₩-39.71 Billion

Industry Comparison

This section compares SillaJen Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $256,967,939,787
  • Average return on equity (ROE) among peers: -5.07%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
SillaJen Inc (215600) ₩117.80 Billion -64.25% 0.06x $200.79 Million
ORIENTBIO Inc. (002630) $60.51 Billion 0.00% 1.04x $69.59 Million
Green Cross (005250) $350.47 Billion 6.04% 6.94x $285.94 Million
Green Cross Holdings Preference Shares (005257) $1.88 Trillion -2.88% 0.99x $2.32 Million
Pharmicell (005690) $76.66 Billion 10.78% 0.43x $418.84 Million
GeneOne Life Science Inc (011000) $36.54 Billion -64.94% 0.25x $164.07 Million
HLB Co. Ltd (028300) $15.50 Billion 0.00% 1.33x $2.78 Billion
Mgenplus Co. Ltd. (032790) $17.78 Billion 0.00% 1.54x $16.18 Million
Daesung Microbiological Labs. Co. Ltd (036480) $19.73 Billion 2.26% 0.29x $15.25 Million
Seoulin Bioscience Co.Ltd (038070) $59.71 Billion 14.88% 0.35x $24.62 Million
Hyundai Bioscience Co. Ltd (048410) $51.22 Billion -16.80% 0.80x $403.52 Million

About SillaJen Inc

KQ:215600 Korea Biotechnology
Market Cap
$200.79 Million
₩296.29 Billion KRW
Market Cap Rank
#16480 Global
#579 in Korea
Share Price
₩2145.00
Change (1 day)
+3.62%
52-Week Range
₩1844.00 - ₩4975.00
All Time High
₩121250.15
About

SillaJen, Inc. engages in developing technologies and products using genetic engineering in South Korea. The company develops Pexa-Vec, which is in phase 2 clinical trial to treat renal Cell Carcinoma and prostate cancer, as well as in phase 1 clinical trial to treat melanoma and solid tumors. It also develops BAL0891, which is in phase 1 clinical trial for the treatment of solid tumors; and SJ-6… Read more